Volume 10, Supplement 1 (Mar 2019)
Volume 10, Supplement 1 (Mar 2019)
Immuno-Oncology Therapy Essentials: Proactive Management of Immune-Related Adverse Events
This supplement, certified for CME/CE/CPE credit, is jointly provided by:



Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
March 17, 2019
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
March 17, 2019
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
March 17, 2019
Advertisement
Current Issue
Vol 17
No 5
Sep/Oct 2026
From Burnout to Resilience Creating Supportive Environments for Oncology Advanced Practitioners
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, TCTCN, FAAN, FAPO
September 16, 2026
Inclusive Leadership and Psychological Safety Among Oncology Advanced Practice Providers
Steven H. Wei, EdD, MPH, MS, PA-C, DFAPPA
September 16, 2026
Understanding PD 1 Inhibitors in Hodgkin Lymphoma A Guide for the Oncology Advanced Practitioner
Maria D. Guerrero, DNP, NP-C, AOCNP , Van Nguyen, DNP, MS, APRN, AGACNP-BC, FNP-C, PMGT-BC
September 16, 2026